SCHEMBL14216852

SCHEMBL14216852

COc1c(O)ccc2c(Cl)nccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
APEX1 P27695 1/20 0.42
PMP22 Q01453 1/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
DYRK1A Q13627 3/20 0.40
MAOA P21397 4/20 0.39
CA1 P00915 2/20 0.35
CA2 P00918 1/20 0.35
ABCB11 O95342 1/20 0.34
TLR8 Q9NR97 2/20 0.34
DYRK3 O43781 1/20 0.34
CLK1 P49759 1/20 0.34
CLK2 P49760 1/20 0.34
CLK3 P49761 1/20 0.34
GSK3B P49841 1/20 0.34
DYRK2 Q92630 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1536585 0.82 MAPK1 (0.44) MAPK1LMNACYP3A4MAPTAPEX1
SCHEMBL1536503 0.81 PDE1B (0.48) MAPK1LMNACYP3A4MAPTAPEX1
SCHEMBL25075454 0.80 CA1 (0.40) LMNAMAPTDYRK1AMAOACA1
SCHEMBL3061434 0.79 MAPK1 (0.42) MAPK1LMNACYP3A4MAPTAPEX1
SCHEMBL9623295 0.79 ESR1 (0.55) MAPK1CYP3A4MAPTESR1ESR2
SCHEMBL15647812 0.76 HIF1A (0.43) MAPK1LMNACYP3A4MAPTAPEX1
SCHEMBL4005339 0.73 LMNA (0.46) MAPK1LMNACYP3A4MAPTAPEX1
SCHEMBL26928380 0.73 LMNA (0.46) MAPK1LMNACYP3A4MAPTAPEX1
SCHEMBL15647758 0.72 KMT2A (0.46) MAPK1LMNACYP3A4MAPTAPEX1
SCHEMBL12266517 0.72 LMNA (0.60) MAPK1LMNACYP3A4MAPTAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2089385-B1 INHIBITORS OF HEPATITIS C VIRUS BRISTOL MYERS SQUIBB CO (US) 2016-01-06 EP disclosed
EP-1951743-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-03-19 EP disclosed
WO-2008057873-A2 INHIBITORS OF HEPATITIS C VIRUS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-05-15 WO disclosed